3 unknown, 1 not yet recruiting. 3 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Gang Wu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of BAI Combined With DEB-BACE of EqualSpheres in the Treatment of Advanced NSCLC BAI combine with DEB-BACE - Carcinoma, Non-Small Cell Lung | Not applicable | Not yet recruiting | Gang Wu | 70 | 2023-12-01 | 2023-11-13 |
| Efficacy and Safety of DEB-BACE With Sequential Arotinib and Tirelizumab in the Treatment of Advanced NSCLC sequential DEB-BACE and Arotinib and Tirelizumab, DEB-BACE alone - Carcinoma, Non-Small Cell Lung | Phase 2 | Unknown | Gang Wu | 60 | 2022-07-01 | 2022-05-18 |
| Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC) Transarterial Chemoembolization - Gastric Cancer, Embolization | Phase 2 | Unknown | Gang Wu | 60 | 2022-06-01 | 2022-05-24 |
| An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC) TACE protocol, Neoadjuvant Chemotherapy - Colorectal Cancer | Phase 2 | Unknown | Gang Wu | 100 | 2022-05-01 | 2022-04-22 |
Carcinoma, Non-Small-Cell Lung (2) · Colorectal Neoplasms (1) · Stomach Neoplasms (1)
China (1)